Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.30 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26029366 | 0.75 | KDM4E (0.38) | KDM4EALDH1A1ADRA2AADRA2CADRA2B | |
| SCHEMBL24872828 | 0.71 | — | — | |
| SCHEMBL20341620 | 0.71 | — | — | |
| SCHEMBL20215587 | 0.69 | CYP2A6 (0.35) | ALDH1A1 | |
| SCHEMBL18588499 | 0.68 | ADRA2A (0.36) | KDM4EALDH1A1ADRA2AADRA2CADRA2B | |
| SCHEMBL87693 | 0.67 | MAPT (0.50) | KDM4EALDH1A1ADRA2AADRA2CADRA2B | |
| SCHEMBL30335572 | 0.67 | MAPT (0.50) | KDM4EALDH1A1ADRA2AADRA2CADRA2B | |
| SCHEMBL29463681 | 0.67 | MAPT (0.50) | KDM4EALDH1A1ADRA2AADRA2CADRA2B | |
| SCHEMBL20312826 | 0.67 | FGF23 (0.36) | KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL8085425 | 0.67 | ADRA2A (0.47) | KDM4EALDH1A1ADRA2AADRA2CADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170222160-A1 | ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME | SFC CO., LTD. (KR) | 2017-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170222160-A1 | ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME | ALDH1A2, LAGE3, AOX1 | KDM4E 1340/4885ALDH1A1 12/4885ADRA2A 921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.